Trial Profile
Study of the Effect of Vildagliptin Versus Dapagliflozin on Glucagon Response to Mixed Meal in Metformin-treated Subjects With Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary) ; Dapagliflozin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 21 Jul 2017 Status changed from active, no longer recruiting to completed.
- 25 Feb 2017 Planned End Date changed from 1 Jun 2017 to 1 Dec 2017.
- 25 Feb 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Jun 2017.